Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma
type: MedicalStudy
description: Phase II Trial of Anti-Angiogenic Therapy With RT-PEPC in Patients With Relapsed Mantle Cell Lymphoma
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2004-11
end date: 2011-04-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00151281
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Weill Medical College of Cornell University
study subject: Non-Hodgkin's Lymphoma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Non-Hodgkin's Lymphoma

AI Analytics
type: Organization